drugset
drugset / Trial / NCT03720392

Fecal Microbiota Transplantation (FMT) in Recipients After Allogeneic Hematopoietic Cell Transplantation (HCT)

NCT03720392 ↗

Phase 2 Terminated 8 enrolled Zachariah Michael DeFilipp
RandomizedParallel-groupDouble-blindTreatment

Summary

This research study is studying the role fecal microbiota transplantation may play in post-Hematopoietic Cell Transplantation (HCT) recipients

Timeline

Start
2019-01-15
Primary completion
2020-05-28
Completion
2020-05-28

Outcome

Outcome not reported

Stopped (Business): “Terminated due to sponsor decision”

Drugs

EvaluationDrugModalityDoseRoute
Subject FMT Other / unclassified 15 unknown Oral

Indications

disease related to hematopoietic stem cell transplant